BioSpace News Archive

Business

bluebird bio Reports First Quarter 2019 Financial Results and Highlights Operational Progress

Company hosting Analyst Day on May 9, 2019 focused on research and commercial strategies

May 2, 2019
·
10 min read
Business

OncLive® Adds Rush University Cancer Center to Its Strategic Alliance Partnership Program

Rush had helped develop some the most advanced cancer therapies available today

May 2, 2019
·
2 min read
Business

Community Healthcare Trust Incorporated Announces the Appointment of Leigh Ann Stach as Executive Vice President and Chief Accounting Officer

Effective May 1, 2019.

May 2, 2019
·
3 min read
Business

Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2019

For the first quarter ended March 31, 2019, net operating revenues increased 5.7% to $1,324.6 million

May 2, 2019
·
22 min read
Watson-Marlow Fluid Technology Group expands BioPure gasket range

Watson-Marlow Fluid Technology Group (WMFTG) announces the launch of the expanded BioPure gasket range, using new materials to cover a wider range of applications to meet the high level of demand for consistent quality in bioprocessing components

May 2, 2019
·
2 min read
Deals

Veracyte Announces Pricing of Public Offering of 5,500,000 Shares of Common Stock - May 2, 2019

Veracyte, Inc. announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a public offering price of $23.25 per share.

May 2, 2019
·
2 min read
Biotech Beach

CytRx Corporation Highlights Arimoclomol Clinical Milestone Guidance Provided by Licensee Orphazyme A/S

CytRx Eligible to Receive up to $120 Million in Future Milestones, Plus Royalties, From Arimoclomol Licensing Agreement

May 2, 2019
·
7 min read
Deals

PDL BioPharma to Announce First Quarter 2019 Financial Results on May 9, 2019

PDL BioPharma, Inc. announced that it will release its first quarter 2019 financial results for the period ended March 31, 2019, on Thursday, May 9, 2019, after market close.

May 2, 2019
·
1 min read
Deals

SQI Diagnostics to Announce Second Quarter 2019 Results

SQI Diagnostics Inc. announced that it plans to release its financial and operational results for the three and six months ended March 31, 2019 at 8:00 a.m. ET Thursday, May 16, 2019.

May 2, 2019
·
2 min read
Drug Development

Ligand Completes Enrollment of Phase 1 Clinical Trial of Captisol-enabled Iohexol

Also reports recent results from clinician survey on radiocontrast agent selection and use

May 2, 2019
·
8 min read